Minerva Surgical Funding & Investors
Minerva Surgical delivers one complete suite of devices that treat the root causes of Abnormal Uterine Bleeding (AUB). With a singular focus on minimally invasive intrauterine treatments, the company has been on the leading edge of significant technological advancements in gynecologic surgery. Minerva Surgical revolutionized the treatment of AUB with the introduction of its namesake product in 2015. The team at Minerva Surgical is wholly dedicated to the prioritization of women's uterine wellness and the advancement of technologies to treat AUB.
minervasurgical.comTotal Amount Raised: $137,702,000
Minerva Surgical Funding Rounds
Series Unknown
$16,700,000
Series Unknown Investors
Novo VenturesSeries Unknown
$20,000,000
Series Unknown Investors
Versant VenturesSeries Unknown
$6,002,000
Series Unknown Investors
New Enterprise Associates (NEA)Post Ipo Equity
$30,000,000
Post Ipo Equity Investors
AccelmedNew Enterprise Associates (NEA)Debt Financing
$40,000,000
Debt Financing Investors
Armentum PartnersSeries Unknown
$25,000,000
Series Unknown Investors
David M. Clapper
Funding info provided by Diffbot.